Inna V. Smagina

Barnaul, ALT, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Clinical and epidemiological characteristics of myasthenia in the Altai region

Clinical and epidemiological characteristics of myasthenia in the Altai region

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: December 18, 2024

Glial fibrillary acidic protein: is there a relationship with the course of multiple sclerosis and traumatic brain injury before the onset of multiple sclerosis?

Glial fibrillary acidic protein: is there a relationship with the course of multiple sclerosis and traumatic brain injury before the onset of multiple sclerosis?

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: November 22, 2024

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 27, 2024

Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population

Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: October 05, 2023

Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 10, 2023

Traumatic brain injury before the multiple sclerosis onset: a relationship with the progression of neurological disorders and pathobiochemical markers of the cerebrospinal fluid

Traumatic brain injury before the multiple sclerosis onset: a relationship with the progression of neurological disorders and pathobiochemical markers of the cerebrospinal fluid

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 10, 2023

Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2

Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 21, 2023

Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational study

Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational study

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 29, 2022

Association of vitamin D metabolism enzyme gene polymorphisms with multiple sclerosis risk: pilot study

Association of vitamin D metabolism enzyme gene polymorphisms with multiple sclerosis risk: pilot study

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 13, 2021

Survey of diagnostic and treatment practices for multiple sclerosis in Russian Federation in comparison to European data.

Survey of diagnostic and treatment practices for multiple sclerosis in Russian Federation in comparison to European data.

Journal: Multiple sclerosis and related disorders

Published: June 26, 2021

Association between vitamin D status and CYP27b1 and CYP24A1 gene polymorphisms in patients with multiple sclerosis in the Altai region

Association between vitamin D status and CYP27b1 and CYP24A1 gene polymorphisms in patients with multiple sclerosis in the Altai region

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 27, 2020

The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis

The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: January 15, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026